[1]
Cedillo, L.M. , Velázquez López, J.D., Bonilla, E.C. , Hernández, R.H. and Jessica, S.G. 2025. BRAF Wild-Type Melanomas with NF1 Mutations: Implications for MEK Inhibitor Therapy in Specific Molecular Subgroups. International Journal of Medical Science and Clinical Research Studies . 5, 09 (Sep. 2025), 1610–1614. DOI:https://doi.org/10.47191/ijmscrs/v5-i09-19.